Renal medullary carcinoma (RMC) is a rare aggressive kidney cancer characterized by the loss of SMARCB1 tumor suppressor and predominantly affects young male adults with SCT and other hemoglobinopathies [102]. This evidence concerns the gene SMARCB1 and kidney cancer.